Pay-for-performance Programs in Radiology
Video: The ACR’s Judy Burleson explains how pay-for-performance and quality measurement programs affect radiologists and how to get involved.
Pay for performance and quality measurement programs don’t just affect primary care physicians. The emergence of new health care models such as accountable care organizations and patient-centered medical homes have put a spotlight on quality improvement for all specialties.
“For radiology groups to win or to add value to those types of organizations they need to support that bottom line in providing quality, safe, efficient imaging services,” said Judy Burleson, director of metrics for the American College of Radiology. She spoke on the topic this month at the annual meeting of the AHRA, association for medical imaging management.
In this video, Burleson addresses how pay for performance programs affect radiology, and what groups should do to understand this trend and get involved.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
